tiprankstipranks
Misonix (MSON)
NASDAQ:MSON
US Market

Misonix (MSON) Stock News & Sentiment

0 Followers
PremiumBlurbs
BTIG Believes Misonix (MSON) Still Has Room to Grow
3y ago
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $26.00. The company’s shares closed last Thursday at $23.84, close to its 52-week high of $24.42. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 29.1% and a 64.1% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Zimmer Biomet Holdings, and Staar Surgical Company. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Misonix with a $24.50 average price target. See today’s analyst top recommended stocks >> Misonix’s market cap is currently $417.6M and has a P/E ratio of -20.60. The company has a Price to Book ratio of 40.97. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company’s ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY. Read More on MSON: William Blair Reaffirms Their Hold Rating on SPS Commerce (SPSC) Cubesmart (CUBE) Gets a Buy Rating from BMO Capital New Sell Rating for International Paper Co (IP), the Energy Giant Chemours Company (CC) Received its Third Buy in a Row Needham Remains a Buy on Teleflex (TFX) ...Read more

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

Not enough data to generate Media Coverage Analysis
The historical news coverage of this asset in the last three months.

FAQ

What is MSON’s Media Buzz Sentiment?
Currently, no data Available
What is MSON’s weekly average amount of articles?
Currently, no data Available
What is MSON’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AMRNAmarin
CLVSClovis Oncology
RCKTRocket Pharmaceuticals
LIVNLivaNova
MTDMettler-Toledo
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis